Navigation path

FP6 projects

Download the PDF version of the projects' catalogue(5.6MB)

ABS INTERNATIONAL Implementing antibiotic strategies (ABS) for appropriate use of antibiotics in hospitals in member states of the European Union
ACE Approaches to control multi-resistant enterococci: studies on molecular ecology, horizontal gene transfer, fitness and prevention
ACE-ART Assessment and critical evaluation of antibiotic resistance transferability in food chain
ActinoGEN Integrating genomics-based applications to exploit actinomycetes as a resource for new antibiotics
AMIS Antimicrobials by immune stimulation
ANTIBIOTARGET Molecular and functional genomic approaches to novel antibacterial target discovery
BACELL HEALTH Bacterial stress management relevant to infectious disease and biopharmaceuticals
BURDEN Burden of resistance and disease in European nations
CanTrain Host-pathogen interaction systems as tools to identify antifungal targets in C. albicans and C. dubliniensis
CHAMP Changing behaviour of healthcare professionals and the general public towards a more prudent use of anti-microbial agents
COBRA Combating resistance to antibiotics by broadening the knowledge on molecular mechanisms behind resistance to inhibitors of cell wall synthesis
COMBIG-TOP Combinatorial biosynthesis of industrial glycopeptides: technology, optimization and production
CombiGyrase Development of new gyrase inhibitors by combinatorial biosynthesis
CRAB Combating resistance to antibiotics
DRESP2 Role of mobile genetic elements in the spread of antimicrobial drug resistance
EACCAD European approach to combat outbreaks of Clostridium difficile associated diarrhoea by development of new diagnostic tests
EAR Effects of antibiotic resistance on bacterial fitness, virulence and transmission
EARSS The European antimicrobial resistance surveillance system
e-Bug Development and dissemination of a school antibiotic and hygiene education pack and website across Europe
ERAPharm Environmental risk assessment of pharmaceuticals
ESAC European surveillance of antimicrobial consumption
ESSTI European surveillance of sexually transmitted infections
ET-PA Enabling techniques for the development of a novel class of protein antibiotics
EUCAST European committee on antimicrobial susceptibility testing
EU-IBIS Invasive bacterial infections surveillance in European Union
EURESFUN Integrated post-genomic approaches for the understanding, detection and prevention of antifungal drug resistance in fungal pathogens
EuResist Integration of viral genomics with clinical data to predict response to anti-HIV treatment
EUR-INTAFAR Inhibition of new targets for fighting antibiotic resistance
Eurofungbase Strategy to build up and maintain an integrated sustainable European fungal genomic database required for innovative genomics research on filamentous fungi important for biotechnology and human health
EPG European virtual institute for functional genomics of bacterial pathogens - EuroPathoGenomics
EuropeHIVResistance European cohort coordinating network on HIV drug resistance
EuroTB Surveillance of tuberculosis in Europe
FUNGWALL The fungal cell wall as a target for antifungal therapies
GENOSEPT Genetics of sepsis in Europe
GRACE Genomics to combat resistance against antibiotics in community-acquired LRTI in Europe
HAPPY AUDIT Health alliance for prudent prescribing, yield and use of antimicrobial drugs in the treatment of respiratory tract infections
IPSE Improving patient safety in Europe
LeishEpiNetSA Control strategies for visceral leishmaniasis (VL) and mucocutaneous leishmaniasis (MCL) in South America: applications of molecular epidemiology
MagRSA Fully automated and integrated microfluidic platform for real-time molecular diagnosis of methicillin-resistant Staphylococcus aureus
MalariaPorin Validation of the plasmodium aquaglyceroporin as a drug target
MANASP Development of novel management strategies for invasive aspergillosis
micro-MATRIX micro-MATRIX: Workshop on strategies to address antimicrobial resistance through the exploitation of microbial genomics
MOSAR Mastering hospital antimicrobial resistance and its spread into the community
NewHiv Targets Identifying novel classes of HIV inhibitors
NEWTBDRUGS New drugs for persistent tuberculosis: exploitation of 3D structure of novel targets, lead optimisation and functional in vivo evaluation
NM4TB New medicines for tuberculosis
NPARI Tailoring of novel peptide coatings and therapeutics derived from a newly identified component of the human innate immunity against resistant infections
Phagevet-P Veterinary phase therapies as alternatives to antibiotics in poultry production
PNEUMOPEP New methods of treatment of antibiotic-resistant pneumococcal disease
PREVIS Pneumococcal resistance epidemicity and virulence - an international study
READ-UP Redox antimalarial drug discovery
REBAVAC Novel opportunities to develop vaccines to control antibiotic resistant bacteria: from the trials back to the laboratory
REPLACE Plants and their extracts and other natural alternatives to antimicrobials in feeds
SAFEWASTES Evaluating physiological and environmental consequences of using organic wastes after technological processing in diets for livestock and humans
SavinMucoPath Novel therapeutic and prophylactic strategies to control mucosal infections by South American bacterial strains
SIGMAL Targeting malaria transmission through interference with signalling in Plasmodium falciparum gametocytogenesis
SLIC Biosensors in molecular diagnostics nanotechnology for the analysis of species-specific microbial transcripts
StaphDynamics Functional genomic characterisation of molecular determinants for staphylococcal fitness, virulence and drug resistance
Tat machine Functional genomic characterisation of the bacterial Tat complex
TB Treatment Marker Establishing a TB treatment efficacy marker
TB-DRUG OLIGOCOLOR Development of a molecular platform for the simultaneous detection of Mycobacterium tuberculosis resistance to rifampicin and fluoroquinolones
TRAINAU Training risk assessment in non-human antimicrobial usage
TRIoH Targeting replication and integration of HIV
Tuberculosis China The diversity of Mycobacterium tuberculosis strains in China: tracing the origins of the worldwide dispersion of the multidrug-resistant Beijing genotype
UNITE-MORE Uniformity in testing and monitoring HIV resistance
VIRGIL European vigilance network for the management of antiviral drug resistance
VIROLAB A virtual lab for decision support in viral diseases treatment
VITBIOMAL Vitamin biosynthesis as a target for antimalarial therapy